About the Event
You’re invited to join us for a webinar with Evecxia Therapeutics. They are developing treatments for severe depression and suicidal ideation which affect 7 million people in the U.S. alone.
70% of people with depression don’t respond to current medication like Prozac and Abilify so the need is both great and urgent. Sign up to hear from Joseph Patti, PhD, President & CEO of Evecxia. You’ll also have the opportunity to ask questions during this informative session.